Form 8-K · Current Report · Filed 2026-08-06
Kenvue Reports Q2 2026 Financial Results with Sales and EPS Growth
Kenvue Inc. announced its financial results for the fiscal second quarter of 2026, reporting a 3.0% increase in net sales and a 9% increase in diluted earnings per share (EPS) to $0.24. The company also saw a 7% increase in adjusted diluted EPS to $0.31. Organic sales increased by 1.6%, driven by gains across all segments and regions. The company's transformation and restructuring initiatives are on track, and it remains focused on completing its value-creating combination with Kimberly-Clark in the fourth quarter of 2026.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001944048-26-000141
- CIK
- 0001944048
- Signal
- Medium impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$19.67
Since filing
+0.0%
Latest close
$19.67
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, KVUE insiders reported 4 Form 4 transactions — flat net activity.
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.